TREA

Michael Jonathan BURY

Follow

Person

  • Collegeville, PA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    MrgX2 antagonists
    • Patent number 11,976,057
    • Issue date May 7, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Edward Brnardic
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Amino-quinolines as kinase inhibitors
    • Patent number 10,220,030
    • Issue date Mar 5, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan Bury
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Amino quinazolines as kinase inhibitors
    • Patent number 9,994,529
    • Issue date Jun 12, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan Bury
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Amino quinazolines as kinase inhibitors
    • Patent number 9,604,938
    • Issue date Mar 28, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan Bury
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Amino-quinolines as kinase inhibitors
    • Patent number 9,604,963
    • Issue date Mar 28, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan Bury
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    MRGX2 ANTAGONISTS
    • Publication number 20220112174
    • Publication date Apr 14, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Edward BRNARDIC
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    AMINO-QUINOLINES AS KINASE INHIBITORS
    • Publication number 20180085365
    • Publication date Mar 29, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan BURY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    AMINO QUINAZOLINES AS KINASE INHIBITORS
    • Publication number 20170152233
    • Publication date Jun 1, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan BURY
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    AMINO-QUINOLINES AS KINASE INHIBITORS
    • Publication number 20170128437
    • Publication date May 11, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan BURY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    AMINO-QUINOLINES AS KINASE INHIBITORS
    • Publication number 20160060222
    • Publication date Mar 3, 2016
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Jonathan BURY
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    AMINO QUINAZOLINES AS KINASE INHIBITORS
    • Publication number 20140206688
    • Publication date Jul 24, 2014
    • Michael Jonathan Bury
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    AMINO-QUINOLINES AS KINASE INHIBITORS
    • Publication number 20130345258
    • Publication date Dec 26, 2013
    • Glaxosmithline LLC
    • Michael Jonathan Bury
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    AMINO-QUINOLINES AS KINASE INHIBITORS
    • Publication number 20130053375
    • Publication date Feb 28, 2013
    • Glaxo Group Limited
    • Michael Jonathan Bury
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE